**Core Concept:** Theophylline is a methylxanthine compound used as a bronchodilator in the management of bronchial asthma. It acts by blocking the breakdown of cyclic AMP and thereby increasing its levels in smooth muscle cells, leading to relaxation of bronchial smooth muscles and reduction of bronchoconstriction.

**Why the Correct Answer is Right:** The correct answer is:

**Option D:** Theophylline does not directly block the release of bronchoconstrictor substances like histamine and leukotrienes from mast cells and basophils. While it may indirectly reduce bronchoconstriction by relaxing the smooth muscles, its primary action is on the smooth muscles themselves, not on the mediators released by inflammatory cells.

**Why Each Wrong Option is Incorrect:**

**Option A:** While theophylline is known to increase cyclic AMP levels, it does not cause a significant increase in cyclic GMP levels, making it less effective in increasing smooth muscle relaxation compared to selective cyclic GMP elevators like sildenafil.

**Option B:** Although theophylline is an effective bronchodilator, it does not directly target the inflammatory cells (e.g., mast cells, basophils) in asthma pathogenesis. Its primary action is on bronchial smooth muscles.

**Option C:** Theophylline does not have any direct anti-inflammatory effects on the airways, unlike corticosteroids that have anti-inflammatory properties. Its primary action is on smooth muscle relaxation, not inflammation.

**Clinical Pearl:** Theophylline is a valuable adjunctive therapy for bronchial asthma, particularly for patients with severe asthma where the primary therapy is corticosteroids. However, it should be used with caution in patients with impaired renal function due to the risk of toxicity.